S. Vashist

Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India

A. Nessa, K. Oswal, N. Bhatla, 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study

E. Zomawia, M. Tommasino, D. Anantharaman, 2020, PloS one.

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

M. Pawlita, E. Zomawia, M. Tommasino, 2019, Papillomavirus research.

Cervical Cancer Screening in HIV-Positive Women in India: Why, When and How?

N. Wig, P. Vanamail, S. Mathur, 2021, The Journal of Obstetrics and Gynecology of India.

Feasibility and Outcome of Training Field Workers to Use the Transvaginal Colposcope for Point of Care Diagnosis and Management of Precancerous Cervical Lesions

Marlee S. Krieger, N. Ramanujam, N. Bhatla, 2022, Indian Journal of Gynecologic Oncology.

Can portable Colposcopes Replace Standard-of-care Colposcopes? A Crossover Trial of Two Portable Colposcopes with a Standard-of-Care Video Colposcope

N. Ramanujam, S. Vishnubhatla, N. Bhatla, 2022, Asian Pacific journal of cancer prevention : APJCP.

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

E. Zomawia, M. Tommasino, D. Anantharaman, 2021, The Lancet. Oncology.

Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination

E. Zomawia, T. Waterboer, P. Sehr, 2022, Vaccine.

Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine

E. Zomawia, T. Waterboer, P. Sehr, 2023, Human Vaccines & Immunotherapeutics.